FDA Drugs recall ·
FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL… recall
- Recall number
- D-0025-2026
- Date
- (initiated October 9, 2025)
- Company / brand
- STAQ Pharma, Inc.
14135 E 42nd Ave Ste 50, Denver, CO, United States - Category
- Drugs › Class III
- Classification
- Class III
- Status
- Ongoing
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.
Why was it recalled?
Labeling: Incorrect or Missing Lot and/or Exp Date
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot: 25102464B, Expiry: 26NOV2025; 25102370A, Expiry: 20OCT2025; 25102369A, Expiry: 19OCT2025.
Distribution
Nationwide in the U.S.
What does Class III mean?
Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).
Source: FDA (drugs), recall D-0025-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.